Advertisement

Related Videos

Russell Szmulewitz, MD, on Alternative Dosing of Abiraterone in Prostate Cancer: Pharmacoeconomic Proof of Concept

Clinical Trial Design: Statistical Options/Challenges Panel Discussion

Opening Session Panel Discussion

Charles Schiffer, MD, on Cost-Effective Use of Tyrosine Kinase Inhibitors for Chronic Myelogenous Leukemia

R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, on Alternative Dispensing Strategies

Advertisement

Advertisement




Nov
24
Today In Oncology
ASTRO Publishes First Clinical Guideline on Radiation Therapy for Gastric Cancer
FDA Approves Pembrolizumab With Enfortumab Vedotin-ejfv for Muscle-Invasive Bladder Cancer
Could Opportunistic Salpingectomy Prevent Ovarian Cancer in Postreproductive Women
Large AI Breast Cancer Screening Trial Increases Detection Rate
Addition of Durvalumab to BCG After TURBT for BCG-Naive, High-Risk NMIBC
View More 
Advertisement
© 2025 HSP News Service, L.L.C.
Conexiant Oncology Logo